A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 330 participants.
Also called NCT05884502
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 330 participants
- Registry
-
NCT05884502
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT05884502. Randomized; no masking; primary purpose treatment. Start 2022-09-01 (actual); primary completion 2023-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke
- Condition
- Dyslipidemias
- Condition
- Stroke, Acute Ischemic
- Intervention (Drug)
- combination of high-dose rosuvastatin and ezetimibe
- Intervention (Drug)
- high-dose rosuvastatin single administration
- Lead sponsor
- Korea University Anam Hospital
Record details
- Record id
cardio:ct-nct05884502- Content hash
25a3441338a17ee51aacb98e8a7a2e19bed8c5f2e42384b460ef34de53ee5737